1.
Almeida LFC de, Silva LFL da, Conceição LD da, Cappellaro AP, Araújo CIC, Lopes CS, et al. Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis. MAST [Internet]. 2026 Feb. 24 [cited 2026 May 20];35(suppl.1). Available from: https://mastology.org/journal/article/view/1195